Literature DB >> 28546431

Disruption of mitochondrial electron transport chain function potentiates the pro-apoptotic effects of MAPK inhibition.

Andrew P Trotta1,2, Jesse D Gelles1,3, Madhavika N Serasinghe1,2, Patrick Loi1, Jack L Arbiser4,5, Jerry E Chipuk6,2,3,7,8.   

Abstract

The mitochondrial network is a major site of ATP production through the coupled integration of the electron transport chain (ETC) with oxidative phosphorylation. In melanoma arising from the V600E mutation in the kinase v-RAF murine sarcoma viral oncogene homolog B (BRAFV600E), oncogenic signaling enhances glucose-dependent metabolism while reducing mitochondrial ATP production. Likewise, when BRAFV600E is pharmacologically inhibited by targeted therapies (e.g. PLX-4032/vemurafenib), glucose metabolism is reduced, and cells increase mitochondrial ATP production to sustain survival. Therefore, collateral inhibition of oncogenic signaling and mitochondrial respiration may help enhance the therapeutic benefit of targeted therapies. Honokiol (HKL) is a well tolerated small molecule that disrupts mitochondrial function; however, its underlying mechanisms and potential utility with targeted anticancer therapies remain unknown. Using wild-type BRAF and BRAFV600E melanoma model systems, we demonstrate here that HKL administration rapidly reduces mitochondrial respiration by broadly inhibiting ETC complexes I, II, and V, resulting in decreased ATP levels. The subsequent energetic crisis induced two cellular responses involving cyclin-dependent kinases (CDKs). First, loss of CDK1-mediated phosphorylation of the mitochondrial division GTPase dynamin-related protein 1 promoted mitochondrial fusion, thus coupling mitochondrial energetic status and morphology. Second, HKL decreased CDK2 activity, leading to G1 cell cycle arrest. Importantly, although pharmacological inhibition of oncogenic MAPK signaling increased ETC activity, co-treatment with HKL ablated this response and vastly enhanced the rate of apoptosis. Collectively, these findings integrate HKL action with mitochondrial respiration and shape and substantiate a pro-survival role of mitochondrial function in melanoma cells after oncogenic MAPK inhibition.

Entities:  

Keywords:  apoptosis; mitochondria; mitochondrial dynamics; mitochondrial respiratory chain complex; oncogene; respiration; targeted therapy

Mesh:

Substances:

Year:  2017        PMID: 28546431      PMCID: PMC5512068          DOI: 10.1074/jbc.M117.786442

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  55 in total

1.  Improved survival with MEK inhibition in BRAF-mutated melanoma.

Authors:  Keith T Flaherty; Caroline Robert; Peter Hersey; Paul Nathan; Claus Garbe; Mohammed Milhem; Lev V Demidov; Jessica C Hassel; Piotr Rutkowski; Peter Mohr; Reinhard Dummer; Uwe Trefzer; James M G Larkin; Jochen Utikal; Brigitte Dreno; Marta Nyakas; Mark R Middleton; Jürgen C Becker; Michelle Casey; Laurie J Sherman; Frank S Wu; Daniele Ouellet; Anne-Marie Martin; Kiran Patel; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2012-06-04       Impact factor: 91.245

Review 2.  The history and future of targeting cyclin-dependent kinases in cancer therapy.

Authors:  Uzma Asghar; Agnieszka K Witkiewicz; Nicholas C Turner; Erik S Knudsen
Journal:  Nat Rev Drug Discov       Date:  2015-02       Impact factor: 84.694

Review 3.  New insights into the function and regulation of mitochondrial fission.

Authors:  Hidenori Otera; Naotada Ishihara; Katsuyoshi Mihara
Journal:  Biochim Biophys Acta       Date:  2013-02-20

4.  Supercomplexes and subcomplexes of mitochondrial oxidative phosphorylation.

Authors:  Ilka Wittig; Rosalba Carrozzo; Filippo M Santorelli; Hermann Schägger
Journal:  Biochim Biophys Acta       Date:  2006-05-12

5.  The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner.

Authors:  Eric W Joseph; Christine A Pratilas; Poulikos I Poulikakos; Madhavi Tadi; Weiqing Wang; Barry S Taylor; Ensar Halilovic; Yogindra Persaud; Feng Xing; Agnes Viale; James Tsai; Paul B Chapman; Gideon Bollag; David B Solit; Neal Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-28       Impact factor: 11.205

6.  Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells.

Authors:  Sumit Arora; Arun Bhardwaj; Sanjeev K Srivastava; Seema Singh; Steven McClellan; Bin Wang; Ajay P Singh
Journal:  PLoS One       Date:  2011-06-24       Impact factor: 3.240

7.  RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).

Authors:  Poulikos I Poulikakos; Yogindra Persaud; Manickam Janakiraman; Xiangju Kong; Charles Ng; Gatien Moriceau; Hubing Shi; Mohammad Atefi; Bjoern Titz; May Tal Gabay; Maayan Salton; Kimberly B Dahlman; Madhavi Tadi; Jennifer A Wargo; Keith T Flaherty; Mark C Kelley; Tom Misteli; Paul B Chapman; Jeffrey A Sosman; Thomas G Graeber; Antoni Ribas; Roger S Lo; Neal Rosen; David B Solit
Journal:  Nature       Date:  2011-11-23       Impact factor: 49.962

8.  The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice.

Authors:  Junko Wakabayashi; Zhongyan Zhang; Nobunao Wakabayashi; Yasushi Tamura; Masahiro Fukaya; Thomas W Kensler; Miho Iijima; Hiromi Sesaki
Journal:  J Cell Biol       Date:  2009-09-14       Impact factor: 10.539

9.  Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3.

Authors:  Vinodkumar B Pillai; Sadhana Samant; Nagalingam R Sundaresan; Hariharasundaram Raghuraman; Gene Kim; Michael Y Bonner; Jack L Arbiser; Douglas I Walker; Dean P Jones; David Gius; Mahesh P Gupta
Journal:  Nat Commun       Date:  2015-04-14       Impact factor: 14.919

10.  Activation of the Mitochondrial Fragmentation Protein DRP1 Correlates with BRAF(V600E) Melanoma.

Authors:  Shira Y Wieder; Madhavika N Serasinghe; Julie C Sung; Daniel C Choi; Miriam B Birge; Jonathan L Yao; Emily Bernstein; Julide T Celebi; Jerry E Chipuk
Journal:  J Invest Dermatol       Date:  2015-06-01       Impact factor: 8.551

View more
  26 in total

1.  Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity.

Authors:  Kevin H Lin; Abigail Xie; Justine C Rutter; Yeong-Ran Ahn; Julia M Lloyd-Cowden; Amanda G Nichols; Ryan S Soderquist; Timothy R Koves; Deborah M Muoio; Nancie J MacIver; Jatinder K Lamba; Timothy S Pardee; Chad M McCall; David A Rizzieri; Kris C Wood
Journal:  Cell Metab       Date:  2019-02-14       Impact factor: 27.287

Review 2.  Mitophagy in tumorigenesis and metastasis.

Authors:  Logan P Poole; Kay F Macleod
Journal:  Cell Mol Life Sci       Date:  2021-02-13       Impact factor: 9.261

3.  Protective properties of the cultured stem cell proteome studied in an animal model of acetaminophen-induced acute liver failure.

Authors:  Andrey Alexandrovich Temnov; Konstantin Arkadevich Rogov; Alla Nikolaevna Sklifas; Elena Valerievna Klychnikova; Markus Hartl; Kristina Djinovic-Carugo; Alexej Charnagalov
Journal:  Mol Biol Rep       Date:  2019-04-12       Impact factor: 2.316

Review 4.  Environmental Chemical Exposures and Mitochondrial Dysfunction: a Review of Recent Literature.

Authors:  Aalekhya Reddam; Sarah McLarnan; Allison Kupsco
Journal:  Curr Environ Health Rep       Date:  2022-07-28

5.  Novel roles of luteinizing hormone (LH) in tissue regeneration-associated functions in endometrial stem cells.

Authors:  Se-Ra Park; Seong-Kwan Kim; Soo-Rim Kim; Jeong-Ran Park; Soyi Lim; In-Sun Hong
Journal:  Cell Death Dis       Date:  2022-07-13       Impact factor: 9.685

6.  In Situ Assembly of Platinum(II)-Metallopeptide Nanostructures Disrupts Energy Homeostasis and Cellular Metabolism.

Authors:  Zhixuan Zhou; Konrad Maxeiner; Pierpaolo Moscariello; Siyuan Xiang; Yingke Wu; Yong Ren; Colette J Whitfield; Lujuan Xu; Anke Kaltbeitzel; Shen Han; David Mücke; Haoyuan Qi; Manfred Wagner; Ute Kaiser; Katharina Landfester; Ingo Lieberwirth; David Y W Ng; Tanja Weil
Journal:  J Am Chem Soc       Date:  2022-06-21       Impact factor: 16.383

7.  Plasticity of Extrachromosomal and Intrachromosomal BRAF Amplifications in Overcoming Targeted Therapy Dosage Challenges.

Authors:  Kai Song; Jenna K Minami; Arthur Huang; Siavash R Dehkordi; Shirley H Lomeli; Jens Luebeck; Mark H Goodman; Gatien Moriceau; Oscar Krijgsman; Prashanthi Dharanipragada; Trevor Ridgley; William P Crosson; Jesus Salazar; Eli Pazol; Gabriel Karin; Rachana Jayaraman; Nikolas G Balanis; Salwan Alhani; Kyle Sheu; Johanna Ten Hoeve; Amelia Palermo; Stephen E Motika; T Niroshi Senaratne; Kim H Paraiso; Paul J Hergenrother; P Nagesh Rao; Asha S Multani; Daniel S Peeper; Vineet Bafna; Roger S Lo; Thomas G Graeber
Journal:  Cancer Discov       Date:  2022-04-01       Impact factor: 38.272

8.  Assessment of Betulinic Acid Cytotoxicity and Mitochondrial Metabolism Impairment in a Human Melanoma Cell Line.

Authors:  Dorina Coricovac; Cristina Adriana Dehelean; Iulia Pinzaru; Alexandra Mioc; Oana-Maria Aburel; Ioana Macasoi; George Andrei Draghici; Crina Petean; Codruta Soica; Madalina Boruga; Brigitha Vlaicu; Mirela Danina Muntean
Journal:  Int J Mol Sci       Date:  2021-05-04       Impact factor: 5.923

9.  Noncanonical functions of glucocorticoids: A novel role for glucocorticoids in performing multiple beneficial functions in endometrial stem cells.

Authors:  Se-Ra Park; Seong-Kwan Kim; Soo-Rim Kim; Doojin Kim; Kun-Woo Kim; In-Sun Hong; Hwa-Yong Lee
Journal:  Cell Death Dis       Date:  2021-06-12       Impact factor: 8.469

10.  N-alkyl triphenylvinylpyridinium conjugated dihydroartemisinin perturbs mitochondrial functions resulting in enhanced cancer versus normal cell toxicity.

Authors:  Mahboubeh Varmazyad; Mira M Modi; Amanda L Kalen; Ehab H Sarsour; Brett Wagner; Juan Du; Michael K Schultz; Garry R Buettner; F Christopher Pigge; Prabhat C Goswami
Journal:  Free Radic Biol Med       Date:  2021-02-06       Impact factor: 8.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.